SCHEMBL529353

SCHEMBL529353

COc1ncc(-c2ccc(N)cc2OC)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.51
IMPDH1 P20839 1/20 0.51
MAP4K4 O95819 1/20 0.45
FYN P06241 4/20 0.44
ALOX5AP P20292 2/20 0.44
FEN1 P39748 2/20 0.44
GAA P10253 2/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
PIK3CA P42336 1/20 0.42
FTO Q9C0B1 3/20 0.41
ALKBH5 Q6P6C2 1/20 0.41
ALDH1A1 P00352 1/20 0.40
NTRK1 P04629 2/20 0.40
KIT P10721 2/20 0.39
CHEK1 O14757 1/20 0.39
DAPK3 O43293 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29764084 0.80 MAPT (0.53) IMPDH2IMPDH1FYNGAAMAPT
SCHEMBL311721 0.80 MAPT (0.53) IMPDH2IMPDH1FYNGAAMAPT
SCHEMBL15995418 0.79 IMPDH2 (0.50) IMPDH2IMPDH1
SCHEMBL3791216 0.78 MAPT (0.52) IMPDH2IMPDH1FYNGAAMAPT
SCHEMBL347390 0.78 MAPT (0.59) IMPDH2IMPDH1GAAMAPTKDM4E
SCHEMBL30839714 0.78 MAPT (0.59) IMPDH2IMPDH1GAAMAPTKDM4E
SCHEMBL21180009 0.78 NPC1 (0.39) MAP4K4FYNALOX5APFEN1GAA
SCHEMBL22446537 0.78 PTGS2 (0.41) MAP4K4FYNALOX5APFEN1FTO
SCHEMBL15741689 0.76 IMPDH2 (0.54) IMPDH2IMPDH1GAAMAPTKDM4E
Hydrochloric Acid SCHEMBL10604756 0.76 MAPT (0.57) IMPDH2IMPDH1GAAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598481-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS Bristol-Myers Squibb Company (US) 2013-06-05 EP disclosed
WO-2012015723-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-02 WO disclosed